Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration
- PMID: 16189139
- PMCID: PMC1251540
- DOI: 10.1128/AAC.49.10.4421-4422.2005
Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration
Figures
References
-
- Butcher, G. A., and R. E. Sinden. 2003. Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro. Am. J. Trop. Med. Hyg. 68:111-114. - PubMed
-
- Edstein, M. D., S. Looareesuwan, C. Viravan, and D. E. Kyle. 1996. Pharmacokinetics of proguanil in malaria patients treated with proguanil plus atovaquone. Southeast Asian J. Trop. Med. Public Health 27:216-220. - PubMed
-
- Hussein, Z., J. Eaves, D. B. Hutchinson, and C. J. Canfield. 1996. Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone. Br. J. Clin. Pharmacol. 42:589-597. - PubMed
-
- Hussein, Z., J. Eaves, D. B. Hutchinson, and C. J. Canfield. 1997. Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin. Pharmacol. Ther. 61:518-530. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources